A biopharmaceutical company engaged in the discovery, development and commercializing of pharmaceutical products
Denali Therapeutics Inc. is a biotechnology company that focuses on the discovery and development of therapies for patients who are suffering from neurodegenerative diseases, including Parkinson’s disease, Alzheimer’s disease, ALS, and more.
BridgeBio is a San Francisco-based biotechnology researching and producing genetically-targeted therapeutics.